The DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index.
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds
Open accessAbstract
The applications of fluorine in drug design continue to expand, facilitated by an improved understanding of its effects on physicochemical properties and the development of synthetic methodologies that are providing access to new fluorinated motifs. In turn, studies of fluorinated molecules are providing deeper insights into the effects of fluorine on metabolic pathways, distribution, and disposition. Despite the high strength of the C-F bond, the departure of fluoride from metabolic intermediates can be facile. This reactivity has been leveraged in the design of mechanism-based enzyme inhibitors and has influenced the metabolic fate of fluorinated compounds. In this Perspective, we summarize the literature associated with the metabolism of fluorinated molecules, focusing on examples where the presence of fluorine influences the metabolic profile. These studies have revealed potentially problematic outcomes with some fluorinated motifs and are enhancing our understanding of how fluorine should be deployed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–242 of 242
Foot, J. S., Deodhar, M., Turner, C. I., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.111 · Cited by 33
Difluorodiazirine. V. difluoromethyl esters and ethers
Mitsch, R. A., & Robertson, J. E. (1965) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570020209 · Cited by 32
Tan, E. Y., Hartmann, G., Chen, Q., Pereira, A., Bradley, S. A., Doss, G. A., Zhang, A. S., Ho, J. Z., Braun, M. P., Dean, D. C., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028696 · Cited by 31
Sharma, R., Sun, H., Piotrowski, D. W., Ryder, T. F., Doran, S. D., Dai, H. I., & Prakash, C. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.047316 · Cited by 31
Earl, R. A., Zaczek, R. C., Teleha, C. A., Fisher, B. N., Maciag, C. M., Marynowski, M. E., Logue, A. R., Tam, S. W., Tinker, W. J., Huang, S. M., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9803424 · Cited by 31
Eichhold, T. H., Hookfin, E. B., Taiwo, Y. O., et al. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(97)00102-7 · Cited by 30
Fluorinated Mechanism-Based Inhibitors: Common Themes and Recent Developments
Tysoe, C., & Withers, S. G. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140202204602 · Cited by 30
Fujinaga, M., Luo, R., Kumata, K., Zhang, Y., Hatori, A., Yamasaki, T., Xie, L., Mori, W., Kurihara, Y., Ogawa, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00374 · Cited by 30
Metabolism of the hydrochlorofluorocarbon 1,2-dichloro-1,1-difluoroethane
Harris, J. W., & Anders, M. W. (1991) · Chemical Research in Toxicology · doi:10.1021/tx00020a009 · Cited by 27
Zhuo, X., Hartz, R. A., Bronson, J. J., Wong, H. H., Ahuja, V. T., Vrudhula, V. M., Leet, J. E., Huang, X. S., Macor, J. E., & Shu, Y. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028910 · Cited by 26
Self-citationA Mechanistic Analysis of Enzymatic Degradation of Organohalogen Compounds
Kurihara, T. (2011) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.100746 · Cited by 26
Purification of a fluoroacetate-specific defluorinase from mouse liver cytosol.
Soiefer, A. I., & Kostyniak, P. J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90581-8 · Cited by 25
On the Mechanism of Dimethylarginine Dimethylaminohydrolase Inactivation by 4-Halopyridines
Johnson, C. M., Monzingo, A. F., Ke, Z., Yoon, D.-W., Linsky, T. W., Guo, H., Robertus, J. D., & Fast, W. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2033684 · Cited by 25
Dollé, F. (2006) · Springer eBooks · doi:10.1007/978-3-540-49527-7_5 · Cited by 23
Pharmacokinetics and Metabolism of Vinyl Fluoridein Vivoandin Vitro
Cantoreggi, S., & Keller, D. A. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8041 · Cited by 23
Metabolism of 1,1-dichloro-2,2,2-trifluoroethane in rats
Urban, G., & Dekant, W. (1994) · Xenobiotica · doi:10.3109/00498259409043287 · Cited by 23
Oxidative and defluorinative metabolism of fludalanine, 2-2H-3-fluoro-D-alanine.
Darland, G. K., Hajdu, R., Kropp, H., Kahan, F. M., Walker, R. W., & VandenHeuvel, W. J. A. (1986) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08992-5 · Cited by 22
Photogeneration of Quinone Methides as Latent Electrophiles for Lysine Targeting
Pérez–Ruíz, R., Molins‐Molina, O., Lence, E., González‐Bello, C., Miranda, M. A., & Jiménez, M. C. (2018) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b01559 · Cited by 22
Kai, H., Hinou, H., & Nishimura, S. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.02.001 · Cited by 21
COOK, E. W., & PIERCE, J. S. (1973) · Nature · doi:10.1038/242337a0 · Cited by 21
Biotransformation of 1,1,1,3,3-Pentafluoropropane (HFC-245fa)
Bayer, T., Amberg, A., Bertermann, R., Rusch, G. M., Anders, M. W., & Dekant, W. (2002) · Chemical Research in Toxicology · doi:10.1021/tx025505c · Cited by 20
Halothane-induced hepatitis: Paradigm or paradox for drug-induced liver injury
Kurth, M. J., Yokoi, T., & Gershwin, E. M. (2014) · Hepatology · doi:10.1002/hep.27253 · Cited by 20
Brullo, C., Massa, M., Villa, C., Ricciarelli, R., Rivera, D., Pronzato, M. A., Fedele, E., Barocelli, E., Bertoni, S., Flammini, L., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.04.027 · Cited by 20
Patel, H., Nemeria, N. S., Andrews, F. H., McLeish, M. J., & Jordan, F. (2014) · Biochemistry · doi:10.1021/bi4015743 · Cited by 18
Hartmann, G., Kumar, S., Johns, D. G., Gheyas, F., Gutstein, D. E., Shen, X., Burton, A., Lederman, H., Lutz, R., Jackson, T., et al. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.067736 · Cited by 18
C−F Bond Activation in Fluorinated Carbonyl Compounds by Chromium Monocations in the Gas Phase
Mazurek, U., Koszinowski, K., & Schwarz, H. (2002) · Organometallics · doi:10.1021/om020646v · Cited by 17
Impact of Minor Structural Modifications on Properties of a Series of mTOR Inhibitors
Ouvry, G., Clary, L., Tomas, L., Aurelly, M., Bonnary, L., Borde, E., Bouix‐Peter, C., Chantalat, L., Defoin-Platel, C., Déret, S., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00401 · Cited by 17
Frankmoelle, W. P., Medina, J. C., Shan, B., Narbut, M. R., & Beckmann, H. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15169-0 · Cited by 16
Mandal, M., Mitra, K., Grotz, D. E., Lin, X. L., Palamanda, J. R., Kumari, P., Buevich, A. V., Caldwell, J. P., Chen, X., Cox, K., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01326 · Cited by 15
Chen, J.-G., Chen, J.-G., Markovitz, D. A., Yang, A. Y., Rabel, S. R., Pang, J., Dolinsky, O., Wu, L., & Alasandro, M. S. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100102039 · Cited by 14
Is fluoroacetate-specific defluorinase a glutathione S-transferase?
Tu, L., Wright, P., Rix, C. J., & Ahokas, J. T. (2006) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2005.12.003 · Cited by 13
Naik, R., Valentine, H., Dannals, R. F., Wong, D. F., & Horti, A. G. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00038 · Cited by 12
Fluorine-containing substituents: metabolism of the α,α-difluoroethyl thioether motif
Rodil, A., Slawin, A. M. Z., Al‐Maharik, N., Tomita, R., & O’Hagan, D. (2019) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.15.144 · Cited by 11
Mechanistic insights into the dehalogenation reaction of fluoroacetate/fluoroacetic acid
Miranda‐Rojas, S., & Toro‐Labbé, A. (2015) · The Journal of Chemical Physics · doi:10.1063/1.4920946 · Cited by 10
Liu, X., Poddar, S. K., Song, L., Hendrickson, H. P., Zhang, X., Yuan, Y., Zhou, D., & Zheng, G. (2020) · ChemMedChem · doi:10.1002/cmdc.201900676 · Cited by 10
Wei, C., Chupak, L. S., Philip, T., Johnson, B. M., Gentles, R. G., & Drexler, D. M. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113492852 · Cited by 9
Self-citationMatsson, E. M., Palm, J. E., Eriksson, U. G., et al. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035022 · Cited by 8
Neilson, A. H. (2002) · Springer eBooks · doi:10.1007/10721878 · Cited by 8
Kostyniak, P. J., & Soiefer, A. I. (1984) · Toxicology Letters · doi:10.1016/0378-4274(84)90069-9 · Cited by 7
Hussainy, R. A., Verbeek, J., van der Born, D., Molthoff, C. F. M., Booij, J., & Herscheid, J. D. M. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.04.002 · Cited by 7
Johns, D. G., LeVoci, L., Krsmanovic, M. L., Lu, M., Hartmann, G., Xu, S. S., Wang, S.-P., Chen, Y., Bateman, T. J., & Blaustein, R. O. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.084525 · Cited by 7
Kuhlmann, O., Paehler, A., Weick, I., et al. (2010) · Xenobiotica · doi:10.3109/00498254.2010.519406 · Cited by 6
Cited by
Marshall, C. M., Federice, J. G., Bell, C. N., Cox, P. B., & Njardarson, J. T. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01122 · Cited by 1,064
U.S. FDA Approved Drugs from 2015–June 2020: A Perspective
Bhutani, P., Joshi, G., Raja, N., Bachhav, N., Rajanna, P. K., Bhutani, H., Paul, A. T., & Kumar, R. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01786 · Cited by 815
Dekant, W., & Dekant, R. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03454-y · Cited by 55
Yue, Y., Fan, J., Xin, G., Huang, Q., Wang, J.-B., Li, Y., Zhang, Q., & Wang, W. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.0c08811 · Cited by 50
Metadata
- Authors
- Johnson, B. M., Shu, Y.-Z., Zhuo, X., & Meanwell, N. A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-03-17
- Volume
- 63
- Issue
- 12
- Pages
- 6315-6386
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3011890716
- Cited by
- 719
- References
- 242
- FWCI
- 68.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.